Welcome to the Andean Pacific HIV Clinical Forum website!
The 1st Andean Pacific HIV Clinical Forum on Integrase Inhibitors will be held on 29 June, 2017 in Santiago, Chile, just prior to our 1st Andean Pacific Workshop on HIV & Hepatitis (30 June – 1 July 2017).
This program is an abstract-driven scientific & educational program dedicated to the integration of science and clinical practice focusing on Integrase Inhibitors.
By joining us, you will be updated on the latest developments related to Integrase, and will be provided with a platform to share your clinical experience. The program will include plenary lectures, Q&A and debate, stimulating interaction in order to bridge the knowledge gap between experts and the HIV treatment community.
This Forum offers a unique platform for discussion on the clinical utility of Integrase Inhibitors in daily practice. After your participation in the meeting, you will be able to:
identify and manage patients who would be eligible for induction-maintenance therapy;
recognize potential drug interactions and, based on this knowledge, develop treatment strategies that could prevent these interactions;
design treatment strategies for different patient populations;
describe and identify the various factors that influence the use of long acting antivirals.
Who should attend?
If you are doing research on or have clinical experience with Integrase Inhibitors or if you are interested in learning more about using Integrase Inhibitors in daily practice, please join us on 29 June, 2017 in Santiago, Chile.
Sheraton Hotel & Convention Center
Sta María 1742, Santiago, Providencia, Región Metropolitana, Chili
Phone: +56 2 2233 5000
We look forward to welcoming you to the meeting in Santiago!
The Program Chairs
More information: http://hiv-clinical-forum.com/1st-andean-pacific-hiv-clinical-forum/
Powered by iCagenda